Repository logo
 

Development of a highly sensitive ELISA for aldosterone in mouse urine: Validation in physiological and pathophysiological states of aldosterone excess and depletion

dc.contributor.authorAl-Dujaili, Emad A. S.
dc.contributor.authorMullins, L. J.
dc.contributor.authorBailey, M. A.
dc.contributor.authorKenyon, C. J.
dc.date.accessioned2018-06-29T21:33:41Z
dc.date.available2018-06-29T21:33:41Z
dc.date.issued2009-04
dc.description.abstractBackground: Clinical studies have established aldosterone as a critical physiological and pathophysiological factor in salt and water homeostasis, blood pressure control and in heart failure. Genetic and physiological studies of mice are used to model these processes. A sensitive and specific assay for aldosterone is therefore needed to monitor adrenocortical activity in murine studies of renal function and cardiovascular diseases. Methods: Antibodies against aldosterone were raised in sheep as previously described. HRP-Donkey-anti-sheep IgG enzyme tracer was produced in our laboratory using the Lightning-Link HRP technique. Aldosterone ELISA protocol was validated and optimised to achieve the best sensitivity. The assay was validated by analysing the urine of mice collected under various experimental conditions designed to stimulate or suppress aldosterone in the presence of other potentially interfering steroid hormones. Results: Cross-reactivity with the steroids most likely to interfere was minimal: corticosterone = 0.0028%, cortisol = 0.0006%, DOC = 0.0048% except for 5-dihydro-aldosterone = 1.65%. Minimum detection limit of this ELISA was 5.2 pmole/L (1.5 pg/mL). The validity of urinary aldosterone ELISA was confirmed by the excellent correlation between results obtained before and after solvent extraction and HPLC separation step (Y = 1.092X + 0.03, R2 = 0.995, n = 54). Accuracy studies, parallelism and imprecision data were determined and all found to be satisfactory. Using this assay, mean urinary aldosterone levels were (i) approximately 60-fold higher in females than males mice; (ii) increased 6-fold by dietary sodium restriction; (iii) increased 10-fold by ACTH infusion and (iv) reduced by >60% in Cyp11b1 null mice. Conclusion: We describe an ELISA for urinary aldosterone that is suitable for repeated non-invasive measurements in mice. Female aldosterone levels are higher than males. Unlike humans, most aldosterone in mouse urine is not conjugated. Increased levels were noted in response to dietary sodium restriction and ACTH treatment. The sensitivity of the assay is sufficient to detect suppressed levels in mouse models of congenital adrenal hyperplasia. 2009 Elsevier Inc. All rights reserved.
dc.description.eprintid706
dc.description.facultysch_die
dc.description.ispublishedpub
dc.description.number04-May
dc.description.statuspub
dc.description.volume74
dc.format.extent456-462
dc.identifierER706
dc.identifier.citationAl-Dujaili, E.A.S., Mullins, L.J., Bailey, M.A. and Kenyon, C.J. (2009) ‘Development of a highly sensitive ELISA for aldosterone in mouse urine: Validation in physiological and pathophysiological states of aldosterone excess and depletion’, Steroids, 74(4–5), pp. 456–462. Available at: https://doi.org/10.1016/j.steroids.2008.12.012.
dc.identifier.doihttp://doi:10.1016/j.steroids.2008.12.012
dc.identifier.issn0039128X
dc.identifier.urihttp://dx.doi.org/10.1016/j.steroids.2008.12.012
dc.identifier.urihttps://eresearch.qmu.ac.uk/handle/20.500.12289/706
dc.relation.ispartofSteroids
dc.subjectACTH
dc.subjectAldosterone
dc.subjectCyp11B1
dc.subjectELISA
dc.subjectSodium intake
dc.subjectUrine
dc.titleDevelopment of a highly sensitive ELISA for aldosterone in mouse urine: Validation in physiological and pathophysiological states of aldosterone excess and depletion
dc.typearticle
dcterms.accessRightspublic
qmu.authorAl-Dujaili, Emad A. S.
rioxxterms.typearticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
eResearch_706.pdf
Size:
358.36 KB
Format:
Adobe Portable Document Format